Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Am J Clin Pathol

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    April 2018
  1. JIANG C, Zhu J, Zhou P, Zhu H, et al
    Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer.
    Am J Clin Pathol. 2018 Apr 5. pii: 4962415. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  2. GONZALEZ RS, Cates JMM, Revetta F, McMahon LA, et al
    Gastric Carcinomas With Lymphoid Stroma: Categorization and Comparison With Solid-Type Colonic Carcinomas.
    Am J Clin Pathol. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  3. LAWLESS ME, Toweill DL, Jewell KD, Jain D, et al
    Massive Gastric Juvenile Polyposis: A Clinicopathologic Study Using SMAD4 Immunohistochemistry.
    Am J Clin Pathol. 2017;147:390.
    PubMed     Text format     Abstract available


    March 2017
  4. FASSAN M, Saraggi D, Balsamo L, Realdon S, et al
    Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.
    Am J Clin Pathol. 2017;147:301-308.
    PubMed     Text format     Abstract available


    December 2016
  5. BARTLEY AN, Washington MK, Ventura CB, Ismaila N, et al
    HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
    Am J Clin Pathol. 2016;146:647-669.
    PubMed     Text format     Abstract available


    September 2016
  6. LIN C, Zhang Z, Xu Y, Wang R, et al
    High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Am J Clin Pathol. 2016;146:278-88.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: